Opening The Impact of Therapy on Glioma Evolution (Yale Cancer Center Grand Rounds)
The Impact of Therapy on Glioma Evolution (Yale Cancer Center Grand Rounds)
- Length
- 52 min
- Level
- Research
- Recorded
- Yale University2024
Chapter 1 of 7: Before the lecture
Glioma evolution under therapy is the subject of Verhaak's Yale Cancer Center Grand Rounds talk, built on multi-timepoint data from the Glioma Longitudinal Analysis (GLASS) Consortium. He starts from the classification of adult gliomas by IDH mutation and 1p/19q co-deletion, then contrasts IDH wild-type and IDH mutant tumors at recurrence. Temozolomide drives hypermutation in a subset of recurrent tumors, while radiation adds small deletions of two to 20 base pairs independently of hypermutation. In irradiated tumors, CDKN2A homozygous deletion tracks with chromosome-arm losses and poor post-recurrence survival. Single-nucleus RNA sequencing then shows shifts toward hypoxia, stem-like and de-differentiated states, especially in recurrent IDH mutant gliomas.

Your comment is kept while you sign up.Sign in
Reads the genomic scars that temozolomide and radiation leave in recurrent gliomas across the GLASS longitudinal cohort.
Glioma evolution under therapy is the subject of Verhaak's Yale Cancer Center Grand Rounds talk, built on multi-timepoint data from the Glioma Longitudinal Analysis (GLASS) Consortium. He starts from the classification of adult gliomas by IDH mutation and 1p/19q co-deletion, then contrasts IDH wild-type and IDH mutant tumors at recurrence. Temozolomide drives hypermutation in a subset of recurrent tumors, while radiation adds small deletions of two to 20 base pairs independently of hypermutation. In irradiated tumors, CDKN2A homozygous deletion tracks with chromosome-arm losses and poor post-recurrence survival. Single-nucleus RNA sequencing then shows shifts toward hypoxia, stem-like and de-differentiated states, especially in recurrent IDH mutant gliomas.
Cancer Cell publication on gene expression subtypes in glioblastoma
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Glioma
Barthel, Johnson et al. GLASS Consortium, Nature, 2019
CATNON study from the EORTC
Kocakavuk et al., Neuro-Onc, 2023
Kocakavuk et al., Nat Genetics, 2021
Wang et al., Cancer Cell, 2017
Verhaak et al., Cancer Cell, 2010
Neftel et al study
Yu et al Natl Sci. Rev., 2020
Multi-biopsy scRNAseq on 9 patients
Cell paper on GBM cell states
Sci Reports paper on MRI hypoxia
Science paper on IDH-mutant glioma
Cell paper on IDH-mutant glioma recurrence
This lecture
Talk 22 of 26 of Yale Cancer Center Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above.
Press a chosen node again to open it.